San Francisco, 21
September 2018: The global assisted reproductive technology (ART) market is expected to reach USD 45 billion by 2025,
according to a new report by Grand View Research, Inc. Childbearing
postponement is one of the high impact rendering drivers of the infertility
treatment market. The reproductive behavior and pattern of some of the nations
such as few European nations have shifted from early to late childbearing
pattern.
Increasing marital age,
rising tobacco and alcohol consumption, increasing obesity rate are some of the
other factors contributing to the market growth. Furthermore, increasing
incidence rate of conditions such as poly-cystic ovarian syndrome (PCOS), tubal
factors and endometriosis are other drivers of the market.
According to the Society
for Assisted Reproductive Technology, 2012 was the year with highest percentage
of babies born through IVF treatment. The treatment has become more successful
and has gained more acceptance, which is further expected to increase the
market size in the coming years.
Access Research Report
of Assisted Reproductive
Technology Market @ www.grandviewresearch.com/industry-analysis/assisted-reproductive-technology-market
Further Key Findings from the Report Suggest:
· Fresh non-donor was the largest ART market
procedure segment in 2014. The fact that fresh eggs and sperms increase the
number of successful pregnancies is expected to drive segment growth over the
forecast period.
· According to a recent study published in
the New England Journal of Medicine.by the researchers from Vietnam and China,
frozen embryos are not more effective in comparison to the fresh embryos for
all women, specifically those suffering from PCOS.
· Frozen non-donor is identified as the most
lucrative procedure segment of the assisted reproductive technology industry. A
new study claims that the fertility treatment with frozen embryos may have more
probability of success than those performed with fresh embryos.
· IVF with ICSI dominated the technology type
market segment owing to increase in the chances of successful fertilization,
and exceptional technique for treating male infertility. As per the study
published in fertility journal Human Reproduction Update 2017, North America,
Europe, New Zealand and Australia, men’s sperm counts declined by 50-60% over
the period between 1973 and 2011. Changing lifestyle and environmental factors
are some of the factors responsible for the decline of sperm counts.
· Frozen embryo replacement (FER) is
anticipated to grow at a rapid rate over the forecast period owing to the fact
that in the clinics fresh embryos are used first and only good quality and
spare embryos are transferred at a later stage. The trend is to transfer single
embryos rather than risking by transferring two or more embryos. This is
expected to increase the FER segment market in the coming years.
· Europe dominated the market and is
anticipated to maintain its dominance during the forecast period The Asia
Pacific region is likely to witness significant growth over the next decade due
to improving healthcare infrastructure, increasing awareness and adoption of
IVF procedures.
· Technological advancements is expected to
drive the market in the coming years. In 2016, INVO Bioscience, Inc. announced
the FDA approval of first intravaginal culture system, INVOcell, wherein
women’s vagina is used as a natural incubator and the clinical trials have
produced pregnancy similar to traditional IVF treatments
· Some of the key players are California
Cryobank, Bloom IVF Centre, Parallabs, OvaScience, Anecova, Origio, Microm
Ltd., Merck KGaA, Ferring Pharmaceuticals, Boston Science Corporation and
Hamilton Throne Ltd.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/biotechnology
Grand View Research has
segmented the global assisted reproductive technology market based on
procedure, type, end use and region:
Procedure Outlook (Revenue, USD Million, 2014 -
2025)
·
Fresh Donor
·
Fresh Non-Donor
·
Frozen Donor
·
Frozen Non-donor
·
Embryo/Egg Banking
Type Outlook(Revenue, USD Million, 2014 - 2025)
·
In-Vitro Fertilization (IVF)
o
IVF with Intracytoplasmic Sperm Injection
(ICSI)
o
IVF without Intracytoplasmic Sperm
Injection (ICSI)
·
AI-IUI (Artificial Insemination -
Intrauterine Insemination
·
Frozen Embryo Replacement (FER)
·
Others
End Use Outlook (Revenue, USD Million, 2014 -
2025)
·
Hospitals
·
Fertility Clinics
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
France
o
Germany
·
Asia Pacific
o
China
o
Japan
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
Access Press Release of
Assisted Reproductive Technology Market@ www.grandviewresearch.com/press-release/global-assisted-reproductive-technology-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
